Guangdong Marubi Biotechnology Co., Ltd.

SHSE:603983 Rapporto sulle azioni

Cap. di mercato: CN¥11.1b

Guangdong Marubi Biotechnology Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Huaiqing Sun

Amministratore delegato

CN¥2.1m

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO12.8yrs
Proprietà del CEO72.7%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione4.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is Now The Time To Put Guangdong Marubi Biotechnology (SHSE:603983) On Your Watchlist?

Nov 22
Is Now The Time To Put Guangdong Marubi Biotechnology (SHSE:603983) On Your Watchlist?

Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher

Sep 26
Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher

Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations

Aug 30
Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations

Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital

Jun 19
Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital

Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet

May 29
Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet

Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?

May 07
Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?

Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion

Mar 27
Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion

Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around

Feb 29
Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around

AMMINISTRATORE DELEGATO

Huaiqing Sun (54 yo)

12.8yrs

Mandato

CN¥2,109,000

Compensazione

Mr. Huaiqing Sun is Chairman and Chief Executive Officer of Guangdong Marubi Biotechnology Co., Ltd. from January 18, 2012.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Huaiqing Sun
Chairman & CEO12.8yrsCN¥2.11m72.72%
CN¥ 8.1b
Kaihui Wang
Director & CFOno dataCN¥2.31mNessun dato
Lingchun Zeng
Chief Marketing Officer & Director6.5yrsCN¥2.08mNessun dato
Yong Cao
Independent Director1.5yrsCN¥58.30kNessun dato
Yi Shen
Director3.7yrsCN¥1.04mNessun dato
Chaowan Guo
Director3.7yrsCN¥832.00kNessun dato
Yalin Bi
Independent Director6.5yrsCN¥100.00kNessun dato
Ka Yeung Chan
Supervisor4.9yrsNessun datoNessun dato
Qingmei Chen
Chairman of the the Supervisory Board4yrsNessun datoNessun dato

4.5yrs

Durata media

46yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 603983 sono considerati esperti (durata media dell'incarico 4.5 anni).